SLC2A1 and colorectal cancer: In the two colorectal cancer cell lines, around 70% decrease in GLUT1 expression resulting from butyrate addition was consistently observed, indicating a prominent role of butyrate in inhibiting glucose metabolism of colorectal cancer cells by reducing the expression level of GLUT1 (Figures 1B,D).